selection media Search Results


95
Chem Impex International paclitaxel
Chemotherapeutic synergy. (a) Isobolograms of MAD1 and Doxorubicin (Dox), <t>Paclitaxel</t> (Ptx) or Cisplatin (Cis) combinatorial synergy in OVCAR-3 (left) and NCI/ADR-RES (right) cells. Fractional inhibitory concentration (FIC) < 1 and < 0.5 represent additive and synergistic effects, respectively. (b) Comparison of Dox and Cis IC50 towards NCI/ADR-RES as either a monotherapy (ADR-RES, black) or in combination with 20 μM MAD1 (ADR-RES + MAD1, grey). Activity of each drug as a monotherapy in pre-resistant OVCAR-3 (OVCAR-3, white) cells shown for comparison. (c–f) Indicated ovarian cancer cell line or patient-derived ovarian carcinoma cells were cultured in ultra-low attachment conditions and treated for 48 h with 2 μM cisplatin or 4 μM MAD1 alone and in combination. Data represent volume in arbitrary units (a.u.) and median.
Paclitaxel, supplied by Chem Impex International, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/selection+media/Paclitaxel/pmc07596148-84-17-21
Average 95 stars, based on 1 article reviews
paclitaxel - by Bioz Stars, 2026-11
95/100 stars
  Buy from Supplier

96
Chem Impex International dye purity
Chemotherapeutic synergy. (a) Isobolograms of MAD1 and Doxorubicin (Dox), <t>Paclitaxel</t> (Ptx) or Cisplatin (Cis) combinatorial synergy in OVCAR-3 (left) and NCI/ADR-RES (right) cells. Fractional inhibitory concentration (FIC) < 1 and < 0.5 represent additive and synergistic effects, respectively. (b) Comparison of Dox and Cis IC50 towards NCI/ADR-RES as either a monotherapy (ADR-RES, black) or in combination with 20 μM MAD1 (ADR-RES + MAD1, grey). Activity of each drug as a monotherapy in pre-resistant OVCAR-3 (OVCAR-3, white) cells shown for comparison. (c–f) Indicated ovarian cancer cell line or patient-derived ovarian carcinoma cells were cultured in ultra-low attachment conditions and treated for 48 h with 2 μM cisplatin or 4 μM MAD1 alone and in combination. Data represent volume in arbitrary units (a.u.) and median.
Dye Purity, supplied by Chem Impex International, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/selection+media/Triclosan/10__1016_slash_j__chemosphere__2016__04__007-37-8-14
Average 96 stars, based on 1 article reviews
dye purity - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

90
apple inc center-mounted buttons on selected models of the ipodtm media player
Chemotherapeutic synergy. (a) Isobolograms of MAD1 and Doxorubicin (Dox), <t>Paclitaxel</t> (Ptx) or Cisplatin (Cis) combinatorial synergy in OVCAR-3 (left) and NCI/ADR-RES (right) cells. Fractional inhibitory concentration (FIC) < 1 and < 0.5 represent additive and synergistic effects, respectively. (b) Comparison of Dox and Cis IC50 towards NCI/ADR-RES as either a monotherapy (ADR-RES, black) or in combination with 20 μM MAD1 (ADR-RES + MAD1, grey). Activity of each drug as a monotherapy in pre-resistant OVCAR-3 (OVCAR-3, white) cells shown for comparison. (c–f) Indicated ovarian cancer cell line or patient-derived ovarian carcinoma cells were cultured in ultra-low attachment conditions and treated for 48 h with 2 μM cisplatin or 4 μM MAD1 alone and in combination. Data represent volume in arbitrary units (a.u.) and median.
Center Mounted Buttons On Selected Models Of The Ipodtm Media Player, supplied by apple inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/selection+media/center+mounted+buttons+on+selected+models+of+the+ipodtm+media+player/us08044314-4-10-15
Average 90 stars, based on 1 article reviews
center-mounted buttons on selected models of the ipodtm media player - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Becton Dickinson selective media cdsa
Chemotherapeutic synergy. (a) Isobolograms of MAD1 and Doxorubicin (Dox), <t>Paclitaxel</t> (Ptx) or Cisplatin (Cis) combinatorial synergy in OVCAR-3 (left) and NCI/ADR-RES (right) cells. Fractional inhibitory concentration (FIC) < 1 and < 0.5 represent additive and synergistic effects, respectively. (b) Comparison of Dox and Cis IC50 towards NCI/ADR-RES as either a monotherapy (ADR-RES, black) or in combination with 20 μM MAD1 (ADR-RES + MAD1, grey). Activity of each drug as a monotherapy in pre-resistant OVCAR-3 (OVCAR-3, white) cells shown for comparison. (c–f) Indicated ovarian cancer cell line or patient-derived ovarian carcinoma cells were cultured in ultra-low attachment conditions and treated for 48 h with 2 μM cisplatin or 4 μM MAD1 alone and in combination. Data represent volume in arbitrary units (a.u.) and median.
Selective Media Cdsa, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/selection+media/selective+media+cdsa/us10076546-2002-16-27
Average 90 stars, based on 1 article reviews
selective media cdsa - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
BD Diagnostics selective growth agar media bd diagnostics
Chemotherapeutic synergy. (a) Isobolograms of MAD1 and Doxorubicin (Dox), <t>Paclitaxel</t> (Ptx) or Cisplatin (Cis) combinatorial synergy in OVCAR-3 (left) and NCI/ADR-RES (right) cells. Fractional inhibitory concentration (FIC) < 1 and < 0.5 represent additive and synergistic effects, respectively. (b) Comparison of Dox and Cis IC50 towards NCI/ADR-RES as either a monotherapy (ADR-RES, black) or in combination with 20 μM MAD1 (ADR-RES + MAD1, grey). Activity of each drug as a monotherapy in pre-resistant OVCAR-3 (OVCAR-3, white) cells shown for comparison. (c–f) Indicated ovarian cancer cell line or patient-derived ovarian carcinoma cells were cultured in ultra-low attachment conditions and treated for 48 h with 2 μM cisplatin or 4 μM MAD1 alone and in combination. Data represent volume in arbitrary units (a.u.) and median.
Selective Growth Agar Media Bd Diagnostics, supplied by BD Diagnostics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/selection+media/selective+growth+agar+media+bd+diagnostics/pm25878170-42-20-23
Average 90 stars, based on 1 article reviews
selective growth agar media bd diagnostics - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Becton Dickinson selective agar culture media and supplements
Chemotherapeutic synergy. (a) Isobolograms of MAD1 and Doxorubicin (Dox), <t>Paclitaxel</t> (Ptx) or Cisplatin (Cis) combinatorial synergy in OVCAR-3 (left) and NCI/ADR-RES (right) cells. Fractional inhibitory concentration (FIC) < 1 and < 0.5 represent additive and synergistic effects, respectively. (b) Comparison of Dox and Cis IC50 towards NCI/ADR-RES as either a monotherapy (ADR-RES, black) or in combination with 20 μM MAD1 (ADR-RES + MAD1, grey). Activity of each drug as a monotherapy in pre-resistant OVCAR-3 (OVCAR-3, white) cells shown for comparison. (c–f) Indicated ovarian cancer cell line or patient-derived ovarian carcinoma cells were cultured in ultra-low attachment conditions and treated for 48 h with 2 μM cisplatin or 4 μM MAD1 alone and in combination. Data represent volume in arbitrary units (a.u.) and median.
Selective Agar Culture Media And Supplements, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/selection+media/selective+agar+culture+media+and+supplements/pmc07223849-67-5-9
Average 90 stars, based on 1 article reviews
selective agar culture media and supplements - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
HiMedia Laboratories vibrio selective media thiosulfate-citrate-bile saltsucrose
Chemotherapeutic synergy. (a) Isobolograms of MAD1 and Doxorubicin (Dox), <t>Paclitaxel</t> (Ptx) or Cisplatin (Cis) combinatorial synergy in OVCAR-3 (left) and NCI/ADR-RES (right) cells. Fractional inhibitory concentration (FIC) < 1 and < 0.5 represent additive and synergistic effects, respectively. (b) Comparison of Dox and Cis IC50 towards NCI/ADR-RES as either a monotherapy (ADR-RES, black) or in combination with 20 μM MAD1 (ADR-RES + MAD1, grey). Activity of each drug as a monotherapy in pre-resistant OVCAR-3 (OVCAR-3, white) cells shown for comparison. (c–f) Indicated ovarian cancer cell line or patient-derived ovarian carcinoma cells were cultured in ultra-low attachment conditions and treated for 48 h with 2 μM cisplatin or 4 μM MAD1 alone and in combination. Data represent volume in arbitrary units (a.u.) and median.
Vibrio Selective Media Thiosulfate Citrate Bile Saltsucrose, supplied by HiMedia Laboratories, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/selection+media/vibrio+selective+media+thiosulfate+citrate+bile+saltsucrose/10__21608_slash_ejabf__2023__296615-46-12-18
Average 90 stars, based on 1 article reviews
vibrio selective media thiosulfate-citrate-bile saltsucrose - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Merck KGaA chromogenic selective media chromoselect bacillus
Growth ( a , c ) and phospholipase C reaction ( b , d ) of inclusivity ( n = 110) and exclusivity ( n = 110) test strains. Negative is no-growth, positive is typical growth and atypical is not presumptive Bacillus cereus sensu lato morphology on selective agar media. Abbreviations: PLC—phospholipase C; MYP—mannitol egg yolk polymyxin agar; CH—CHROMagar™ B. cereus ; BA—BACARA ® agar; <t>HI—ChromoSelect</t> Bacillus agar; BRI—Brilliance™ B. cereus agar.
Chromogenic Selective Media Chromoselect Bacillus, supplied by Merck KGaA, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/selection+media/chromogenic+selective+media+chromoselect+bacillus/pmc08834558-29-11-17
Average 90 stars, based on 1 article reviews
chromogenic selective media chromoselect bacillus - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Romer Labs Inc selective romer labs’ primary media with phage supplement
Growth ( a , c ) and phospholipase C reaction ( b , d ) of inclusivity ( n = 110) and exclusivity ( n = 110) test strains. Negative is no-growth, positive is typical growth and atypical is not presumptive Bacillus cereus sensu lato morphology on selective agar media. Abbreviations: PLC—phospholipase C; MYP—mannitol egg yolk polymyxin agar; CH—CHROMagar™ B. cereus ; BA—BACARA ® agar; <t>HI—ChromoSelect</t> Bacillus agar; BRI—Brilliance™ B. cereus agar.
Selective Romer Labs’ Primary Media With Phage Supplement, supplied by Romer Labs Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/selection+media/selective+romer+labs%E2%80%99+primary+media+with+phage+supplement/pm28717239-154-54-49
Average 90 stars, based on 1 article reviews
selective romer labs’ primary media with phage supplement - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
STEMCELL Technologies Inc rosette selection media
Growth ( a , c ) and phospholipase C reaction ( b , d ) of inclusivity ( n = 110) and exclusivity ( n = 110) test strains. Negative is no-growth, positive is typical growth and atypical is not presumptive Bacillus cereus sensu lato morphology on selective agar media. Abbreviations: PLC—phospholipase C; MYP—mannitol egg yolk polymyxin agar; CH—CHROMagar™ B. cereus ; BA—BACARA ® agar; <t>HI—ChromoSelect</t> Bacillus agar; BRI—Brilliance™ B. cereus agar.
Rosette Selection Media, supplied by STEMCELL Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/selection+media/rosette+selection+media/pmc04707261-66-11-14
Average 90 stars, based on 1 article reviews
rosette selection media - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Becton Dickinson bbl chromagartm mrsa ii selective media
Growth ( a , c ) and phospholipase C reaction ( b , d ) of inclusivity ( n = 110) and exclusivity ( n = 110) test strains. Negative is no-growth, positive is typical growth and atypical is not presumptive Bacillus cereus sensu lato morphology on selective agar media. Abbreviations: PLC—phospholipase C; MYP—mannitol egg yolk polymyxin agar; CH—CHROMagar™ B. cereus ; BA—BACARA ® agar; <t>HI—ChromoSelect</t> Bacillus agar; BRI—Brilliance™ B. cereus agar.
Bbl Chromagartm Mrsa Ii Selective Media, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/selection+media/bbl+chromagartm+mrsa+ii+selective+media/pm39535214-46-16-14
Average 90 stars, based on 1 article reviews
bbl chromagartm mrsa ii selective media - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Becton Dickinson standard selective media anaerobic systems
Growth ( a , c ) and phospholipase C reaction ( b , d ) of inclusivity ( n = 110) and exclusivity ( n = 110) test strains. Negative is no-growth, positive is typical growth and atypical is not presumptive Bacillus cereus sensu lato morphology on selective agar media. Abbreviations: PLC—phospholipase C; MYP—mannitol egg yolk polymyxin agar; CH—CHROMagar™ B. cereus ; BA—BACARA ® agar; <t>HI—ChromoSelect</t> Bacillus agar; BRI—Brilliance™ B. cereus agar.
Standard Selective Media Anaerobic Systems, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/selection+media/standard+selective+media+anaerobic+systems/10__1128_slash_iai__72__7__3793___3802__2004-62-18-24
Average 90 stars, based on 1 article reviews
standard selective media anaerobic systems - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

Image Search Results


Chemotherapeutic synergy. (a) Isobolograms of MAD1 and Doxorubicin (Dox), Paclitaxel (Ptx) or Cisplatin (Cis) combinatorial synergy in OVCAR-3 (left) and NCI/ADR-RES (right) cells. Fractional inhibitory concentration (FIC) < 1 and < 0.5 represent additive and synergistic effects, respectively. (b) Comparison of Dox and Cis IC50 towards NCI/ADR-RES as either a monotherapy (ADR-RES, black) or in combination with 20 μM MAD1 (ADR-RES + MAD1, grey). Activity of each drug as a monotherapy in pre-resistant OVCAR-3 (OVCAR-3, white) cells shown for comparison. (c–f) Indicated ovarian cancer cell line or patient-derived ovarian carcinoma cells were cultured in ultra-low attachment conditions and treated for 48 h with 2 μM cisplatin or 4 μM MAD1 alone and in combination. Data represent volume in arbitrary units (a.u.) and median.

Journal: Cellular and Molecular Bioengineering

Article Title: Re-engineering Antimicrobial Peptides into Oncolytics Targeting Drug-Resistant Ovarian Cancers

doi: 10.1007/s12195-020-00626-z

Figure Lengend Snippet: Chemotherapeutic synergy. (a) Isobolograms of MAD1 and Doxorubicin (Dox), Paclitaxel (Ptx) or Cisplatin (Cis) combinatorial synergy in OVCAR-3 (left) and NCI/ADR-RES (right) cells. Fractional inhibitory concentration (FIC) < 1 and < 0.5 represent additive and synergistic effects, respectively. (b) Comparison of Dox and Cis IC50 towards NCI/ADR-RES as either a monotherapy (ADR-RES, black) or in combination with 20 μM MAD1 (ADR-RES + MAD1, grey). Activity of each drug as a monotherapy in pre-resistant OVCAR-3 (OVCAR-3, white) cells shown for comparison. (c–f) Indicated ovarian cancer cell line or patient-derived ovarian carcinoma cells were cultured in ultra-low attachment conditions and treated for 48 h with 2 μM cisplatin or 4 μM MAD1 alone and in combination. Data represent volume in arbitrary units (a.u.) and median.

Article Snippet: 3-(4,5-Dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide (MTT), Fmoc-protected amino acids, N,N 0 -diisopropylcarbodiimide (DIC), O-(7-Azabenzotriazol-1-yl)-N,N,N’,N’-tetramethyluronium hexafluorophosphate (HATU), N,N -dimethylformamide (DMF), and Paclitaxel were purchased from Chem-Impex International, Inc. RPMI-1640, M199, trypsin and EDTA solution, Antibiotic-Antimycotic Solution, ultra-low attachment (ULA) plates, and 1× phosphate buffered saline (PBS) were purchased from Corning.

Techniques: Concentration Assay, Comparison, Activity Assay, Derivative Assay, Cell Culture

Growth ( a , c ) and phospholipase C reaction ( b , d ) of inclusivity ( n = 110) and exclusivity ( n = 110) test strains. Negative is no-growth, positive is typical growth and atypical is not presumptive Bacillus cereus sensu lato morphology on selective agar media. Abbreviations: PLC—phospholipase C; MYP—mannitol egg yolk polymyxin agar; CH—CHROMagar™ B. cereus ; BA—BACARA ® agar; HI—ChromoSelect Bacillus agar; BRI—Brilliance™ B. cereus agar.

Journal: Foods

Article Title: Performance Testing of Bacillus cereus Chromogenic Agar Media for Improved Detection in Milk and Other Food Samples

doi: 10.3390/foods11030288

Figure Lengend Snippet: Growth ( a , c ) and phospholipase C reaction ( b , d ) of inclusivity ( n = 110) and exclusivity ( n = 110) test strains. Negative is no-growth, positive is typical growth and atypical is not presumptive Bacillus cereus sensu lato morphology on selective agar media. Abbreviations: PLC—phospholipase C; MYP—mannitol egg yolk polymyxin agar; CH—CHROMagar™ B. cereus ; BA—BACARA ® agar; HI—ChromoSelect Bacillus agar; BRI—Brilliance™ B. cereus agar.

Article Snippet: Within the scope of this study, the performance of commercially available chromogenic selective media ChromoSelect Bacillus (HI; Merck KgaA, Darmstadt, Germany; formerly branded HiCromeTM Bacillus ), CHROMagarTM B. cereus (CH; CHROMagar, Paris, France), BrillianceTM B. cereus (BRI; Thermo Fisher Scientific Inc., Oxoid, Waltham, MA, USA) and BACARA ® agar (BA; B. cereus Rapid Agar; bioMérieux, Marcy l’Etoile, France) was evaluated in comparison to the ISO recommended standard medium MYP [ ] (Thermo Fisher Scientific Inc., Oxoid, Waltham, MA, USA).

Techniques:

Typical ( A – E ) and atypical colonies ( F – J ) of Bacillus cereus sensu lato on MYP agar (A (BCG 6), F (BC 66)), ChromoSelect Bacillus agar (B (BC 30), G (BC 20)), Brilliance™ B. cereus agar (C (BC 2), H (BC 19)), CHROMagar™ B. cereus (D (BC 63), I (BC 2)) and BACARA ® agar (E (BC 50), J (BC 34)). Bluish-green colonies are the result of β-D-glucosidase reaction. Precipitation zones surrounding typical colonies are caused by phospholipase C reaction, while lack of mannitol fermentation results in pink background. Abbreviations: MYP—mannitol egg yolk polymyxin agar; HI—ChromoSelect Bacillus agar; BRI—Brilliance™ B. cereus agar; CH—CHROMagar™ Bacillus cereus ; BA—BACARA ® agar.

Journal: Foods

Article Title: Performance Testing of Bacillus cereus Chromogenic Agar Media for Improved Detection in Milk and Other Food Samples

doi: 10.3390/foods11030288

Figure Lengend Snippet: Typical ( A – E ) and atypical colonies ( F – J ) of Bacillus cereus sensu lato on MYP agar (A (BCG 6), F (BC 66)), ChromoSelect Bacillus agar (B (BC 30), G (BC 20)), Brilliance™ B. cereus agar (C (BC 2), H (BC 19)), CHROMagar™ B. cereus (D (BC 63), I (BC 2)) and BACARA ® agar (E (BC 50), J (BC 34)). Bluish-green colonies are the result of β-D-glucosidase reaction. Precipitation zones surrounding typical colonies are caused by phospholipase C reaction, while lack of mannitol fermentation results in pink background. Abbreviations: MYP—mannitol egg yolk polymyxin agar; HI—ChromoSelect Bacillus agar; BRI—Brilliance™ B. cereus agar; CH—CHROMagar™ Bacillus cereus ; BA—BACARA ® agar.

Article Snippet: Within the scope of this study, the performance of commercially available chromogenic selective media ChromoSelect Bacillus (HI; Merck KgaA, Darmstadt, Germany; formerly branded HiCromeTM Bacillus ), CHROMagarTM B. cereus (CH; CHROMagar, Paris, France), BrillianceTM B. cereus (BRI; Thermo Fisher Scientific Inc., Oxoid, Waltham, MA, USA) and BACARA ® agar (BA; B. cereus Rapid Agar; bioMérieux, Marcy l’Etoile, France) was evaluated in comparison to the ISO recommended standard medium MYP [ ] (Thermo Fisher Scientific Inc., Oxoid, Waltham, MA, USA).

Techniques:

Growth of non-target organisms on Bacillus cereus selective media (from upper left to lower right). MYP agar: ( A )— Serratia marcescens (EGN 54); ( B )— Brochothrix thermospacta (EGP 2); ( C )— Bacillus stratosphericus (BG 28). ChromoSelect Bacillus agar: ( D )— Aeromonas hydrophila (EGN 5); ( E )— Acinetobacter baumannii (EGN 2); ( F )— Citrobacter freundii (EGN 9). Brilliance™ B. cereus agar: ( G )— Staphylococcus sciuri (EGP 13); ( H )— Serratia marcescens (EGN 54); ( I )— Pseudomonas fluorescens (EGN 45). CHROMagar™ B. cereus : ( J )— Morganella morganii (EGN 39); ( K )— Enterococcus faecalis (EGP 5); ( L )— Providencia rettgeri (EGN 42). BACARA ® agar: ( M )— Staphylococcus haemolyticus (EGP 11); ( N )— Staphylococcus chromogenes (EGP 9); ( O )– Listeria monocytogenes (EGP 22). Abbreviations: MYP—mannitol egg yolk polymyxin agar; HI—ChromoSelect Bacillus agar; BRI—Brilliance™ B. cereus agar; CH—CHROMagar™ Bacillus cereus ; BA—BACARA ® agar.

Journal: Foods

Article Title: Performance Testing of Bacillus cereus Chromogenic Agar Media for Improved Detection in Milk and Other Food Samples

doi: 10.3390/foods11030288

Figure Lengend Snippet: Growth of non-target organisms on Bacillus cereus selective media (from upper left to lower right). MYP agar: ( A )— Serratia marcescens (EGN 54); ( B )— Brochothrix thermospacta (EGP 2); ( C )— Bacillus stratosphericus (BG 28). ChromoSelect Bacillus agar: ( D )— Aeromonas hydrophila (EGN 5); ( E )— Acinetobacter baumannii (EGN 2); ( F )— Citrobacter freundii (EGN 9). Brilliance™ B. cereus agar: ( G )— Staphylococcus sciuri (EGP 13); ( H )— Serratia marcescens (EGN 54); ( I )— Pseudomonas fluorescens (EGN 45). CHROMagar™ B. cereus : ( J )— Morganella morganii (EGN 39); ( K )— Enterococcus faecalis (EGP 5); ( L )— Providencia rettgeri (EGN 42). BACARA ® agar: ( M )— Staphylococcus haemolyticus (EGP 11); ( N )— Staphylococcus chromogenes (EGP 9); ( O )– Listeria monocytogenes (EGP 22). Abbreviations: MYP—mannitol egg yolk polymyxin agar; HI—ChromoSelect Bacillus agar; BRI—Brilliance™ B. cereus agar; CH—CHROMagar™ Bacillus cereus ; BA—BACARA ® agar.

Article Snippet: Within the scope of this study, the performance of commercially available chromogenic selective media ChromoSelect Bacillus (HI; Merck KgaA, Darmstadt, Germany; formerly branded HiCromeTM Bacillus ), CHROMagarTM B. cereus (CH; CHROMagar, Paris, France), BrillianceTM B. cereus (BRI; Thermo Fisher Scientific Inc., Oxoid, Waltham, MA, USA) and BACARA ® agar (BA; B. cereus Rapid Agar; bioMérieux, Marcy l’Etoile, France) was evaluated in comparison to the ISO recommended standard medium MYP [ ] (Thermo Fisher Scientific Inc., Oxoid, Waltham, MA, USA).

Techniques:

Examples of typical Bacillus cereus sensu lato colonies obtained by sampling of naturally contaminated food ans milk samples. Demarcated colonies with typical morphology (top row): ( A )—MYP agar (ESL-milk); ( B )—HI, ChromoSelect Bacillus agar (ESL-goat milk); ( C )—Brilliance™ B. cereus agar (ESL-milk); ( D )—CHROMagar™ B. cereus (ESL-milk); ( E )—BACARA ® agar (ESL-milk). Colonies masked by high growth of background flora and atypical morphologies (bottom row; arrows point on typical B. cereus colonies): ( F )—coalescing B. cereus colonies surrounded by mannitol-positive background-flora ( B. licheniformis ) on MYP agar (dried fish snack); ( G )—mixed culture on ChromoSelect Bacillus agar, growth of mannitol-positive background-flora ( Staphylococcus spp.) intersparsed with typical colonies (raw milk); ( H )—atypical light colonies with weak β-D-glucosidase activity and typical colonies on Brilliance™ B. cereus agar (ESL-milk); ( I )—atypical PLC-negative and weakly β-D-glucosidase positive colonies lacking the distinctive halo together with typical colony on CHROMagar™ B. cereus (Chinese water spinach); ( J )—atypical small colonies with weak PLC acitivity on BACARA ® agar (dried fish snack). Abbreviations: MYP—mannitol egg yolk polymyxin agar; HI—ChromoSelect Bacillus agar; BRI—Brilliance™ B. cereus agar; CH—CHROMagar™ B. cereus ; BA—BACARA ® agar.

Journal: Foods

Article Title: Performance Testing of Bacillus cereus Chromogenic Agar Media for Improved Detection in Milk and Other Food Samples

doi: 10.3390/foods11030288

Figure Lengend Snippet: Examples of typical Bacillus cereus sensu lato colonies obtained by sampling of naturally contaminated food ans milk samples. Demarcated colonies with typical morphology (top row): ( A )—MYP agar (ESL-milk); ( B )—HI, ChromoSelect Bacillus agar (ESL-goat milk); ( C )—Brilliance™ B. cereus agar (ESL-milk); ( D )—CHROMagar™ B. cereus (ESL-milk); ( E )—BACARA ® agar (ESL-milk). Colonies masked by high growth of background flora and atypical morphologies (bottom row; arrows point on typical B. cereus colonies): ( F )—coalescing B. cereus colonies surrounded by mannitol-positive background-flora ( B. licheniformis ) on MYP agar (dried fish snack); ( G )—mixed culture on ChromoSelect Bacillus agar, growth of mannitol-positive background-flora ( Staphylococcus spp.) intersparsed with typical colonies (raw milk); ( H )—atypical light colonies with weak β-D-glucosidase activity and typical colonies on Brilliance™ B. cereus agar (ESL-milk); ( I )—atypical PLC-negative and weakly β-D-glucosidase positive colonies lacking the distinctive halo together with typical colony on CHROMagar™ B. cereus (Chinese water spinach); ( J )—atypical small colonies with weak PLC acitivity on BACARA ® agar (dried fish snack). Abbreviations: MYP—mannitol egg yolk polymyxin agar; HI—ChromoSelect Bacillus agar; BRI—Brilliance™ B. cereus agar; CH—CHROMagar™ B. cereus ; BA—BACARA ® agar.

Article Snippet: Within the scope of this study, the performance of commercially available chromogenic selective media ChromoSelect Bacillus (HI; Merck KgaA, Darmstadt, Germany; formerly branded HiCromeTM Bacillus ), CHROMagarTM B. cereus (CH; CHROMagar, Paris, France), BrillianceTM B. cereus (BRI; Thermo Fisher Scientific Inc., Oxoid, Waltham, MA, USA) and BACARA ® agar (BA; B. cereus Rapid Agar; bioMérieux, Marcy l’Etoile, France) was evaluated in comparison to the ISO recommended standard medium MYP [ ] (Thermo Fisher Scientific Inc., Oxoid, Waltham, MA, USA).

Techniques: Sampling, Activity Assay

Detectability of Bacillus cereus sensu lato in 64 naturally contaminated food samples before freezing on MYP agar and after freezing on MYP agar and chromogenic media. Abbreviations: MYP—mannitol egg yolk polymyxin agar; BA—BACARA ® agar; CH—CHROMagar™ Bacillus cereus ; BRI—Brilliance™ B. cereus agar; HI—ChromoSelect Bacillus agar.

Journal: Foods

Article Title: Performance Testing of Bacillus cereus Chromogenic Agar Media for Improved Detection in Milk and Other Food Samples

doi: 10.3390/foods11030288

Figure Lengend Snippet: Detectability of Bacillus cereus sensu lato in 64 naturally contaminated food samples before freezing on MYP agar and after freezing on MYP agar and chromogenic media. Abbreviations: MYP—mannitol egg yolk polymyxin agar; BA—BACARA ® agar; CH—CHROMagar™ Bacillus cereus ; BRI—Brilliance™ B. cereus agar; HI—ChromoSelect Bacillus agar.

Article Snippet: Within the scope of this study, the performance of commercially available chromogenic selective media ChromoSelect Bacillus (HI; Merck KgaA, Darmstadt, Germany; formerly branded HiCromeTM Bacillus ), CHROMagarTM B. cereus (CH; CHROMagar, Paris, France), BrillianceTM B. cereus (BRI; Thermo Fisher Scientific Inc., Oxoid, Waltham, MA, USA) and BACARA ® agar (BA; B. cereus Rapid Agar; bioMérieux, Marcy l’Etoile, France) was evaluated in comparison to the ISO recommended standard medium MYP [ ] (Thermo Fisher Scientific Inc., Oxoid, Waltham, MA, USA).

Techniques: